Current perspectives in the management of hyponatremia: prevention of CPM

References

• Rowntree LG. Effects on mammals of the administration of excessive quantities of water. J. Pharmacol. Exp. Therapeut.29, 135–159 (1926).
   Google Scholar
• Helwig FC, Schutz CB, Curry DE. Water intoxication. Report of a fatal case, with clinical, pathologic and experimental studies. JAMA104, 1539–1575 (1935).
   Google Scholar
• Helwig FC, Schutz CB, Kuhn HP. Water intoxication. Moribund patient cured by administration of hypertonic salt solution. JAMA110, 644–645 (1938).
   Google Scholar
• Loas G, Mercier-Guidez E. Fatal self-induced water intoxication among schizophrenic inpatients. Eur. Psychiatry17, 307–310 (2002).
   PubMedGoogle Scholar
• Almond CS, Shin AY, Fortescue EB et al. Hyponatremia among runners in the Boston Marathon. N. Engl. J. Med.352, 1550–1556 (2005).
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Nguyen MK, Chang R, Kurtz I. Fatal hyponatremia in a young woman after ecstasy ingestion. Nat. Clin. Pract. Nephrol.2, 283–288 (2006).
   PubMedGoogle Scholar
• Stiefel D, Petzold A. H2O coma. Neurocrit. Care6, 67–71 (2007).
   PubMedGoogle Scholar
• Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N. Engl. J. Med.314, 1529–1535 (1986).
   PubMed Web of Science ®Google Scholar
• Achinger SG, Moritz ML, Ayus JC. Dysnatremias: why are patients still dying? South. Med. J.99, 353–362 (2006).
   PubMed Web of Science ®Google Scholar
• Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest107, 517–521 (1995).
   PubMed Web of Science ®Google Scholar
• Vexler ZS, Ayus JC, Roberts TP, Fraser CL, Kucharczyk J, Arieff AI. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. J. Clin. Invest.93, 256–264 (1994).
   PubMed Web of Science ®Google Scholar
• Hew-Butler T, Almond C, Ayus JC et al. Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference Cape Town South Africa 2005. Clin. J. Sport Med.15, 208–213 (2005).
   PubMed Web of Science ®Google Scholar
• Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am. J. Med.119, S12–S16 (2006).
   Web of Science ®Google Scholar
• Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int.35, 69–75 (1989).
   PubMed Web of Science ®Google Scholar
• Trachtman H. Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II. Pediatr. Nephrol.6, 104–112 (1992).
   PubMedGoogle Scholar
• Sterns RH, Baer J, Ebersol S, Thomas D, Lohr JW, Kamm DE. Organic osmolytes in acute hyponatremia. Am. J. Physiol.264, F833–F836 (1993).
   Google Scholar
• Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res.567, 274–282 (1991).
   PubMed Web of Science ®Google Scholar
• Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J. Clin. Invest.88, 303–309 (1991).
   PubMedGoogle Scholar
• Chow KM, Kwan BC, Szeto CC. Clinical studies of thiazide-induced hyponatremia. J. Natl Med. Assoc.96, 1305–1308 (2004).
   PubMedGoogle Scholar
• Sterns RH. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann. Intern. Med.107, 656–664 (1987).
   PubMed Web of Science ®Google Scholar
• Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J. Am. Soc. Nephrol.4, 1522–1530 (1994).
   PubMed Web of Science ®Google Scholar
• Ellis SJ. Severe hyponatraemia: complications and treatment. QJM88, 905–909 (1995).
   PubMed Web of Science ®Google Scholar
• Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch. Neurol. Psychiatry81, 154–172 (1959).
   PubMedGoogle Scholar
• Burcar PJ, Norenberg MD, Yarnell PR. Hyponatremia and central pontine myelinolysis. Neurology27, 223–226 (1977).
   PubMed Web of Science ®Google Scholar
• Messert B, Orrison WW, Hawkins MJ, Quaglieri CE. Central pontine myelinolysis. Considerations on etiology, diagnosis, and treatment. Neurology29, 147–160 (1979).
   PubMed Web of Science ®Google Scholar
• Tomlinson BE, Pierides AM, Bradley WG. Central pontine myelinolysis. Two cases with associated electrolyte disturbance. QJM45, 373–386 (1976).
   PubMedGoogle Scholar
• Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then … and now. J. Neuropathol. Exp. Neurol.65, 1–11 (2006).
   PubMed Web of Science ®Google Scholar
• Norenberg MD, Leslie KO, Robertson AS. Association between rise in serum sodium and central pontine myelinolysis. Ann. Neurol.11, 128–135 (1982).
   PubMedGoogle Scholar
• Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain102, 361–385 (1979).
   PubMed Web of Science ®Google Scholar
• Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin. Neuropathol.6, 262–270 (1987).
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK, Norenberg MD. Neuropathologic observations in electrolyte-induced myelinolysis in the rat. J. Neuropathol. Exp. Neurol.41, 67–80 (1982).
   PubMedGoogle Scholar
• Kleinschmidt-DeMasters BK, Norenberg MD. Cerebellar degeneration in the rat following rapid correction of hyponatremia. Ann. Neurol.10, 561–565 (1981).
   PubMedGoogle Scholar
• Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science211, 1068–1070 (1981).
   PubMedGoogle Scholar
• Laureno R. Rapid correction of hyponatremia: cause of pontine myelinolysis? Am. J. Med.71, 846–847 (1981).
   PubMedGoogle Scholar
• Laureno R. Experimental pontine and extrapontine myelinolysis. Trans. Am. Neurol. Assoc.105, 354–358 (1980).
   PubMedGoogle Scholar
• Rojiani AM, Prineas JW, Cho ES. Protective effect of steroids in electrolyte-induced demyelination. J. Neuropathol. Exp. Neurol.46, 495–504 (1987).
   PubMedGoogle Scholar
• Rojiani AM, Prineas JW, Cho ES. Electrolyte-induced demyelination in rats. 1. Role of the blood–brain barrier and edema. Acta Neuropathol. (Berl.)88, 287–292 (1994).
   PubMedGoogle Scholar
• Rojiani AM, Cho ES, Sharer L, Prineas JW. Electrolyte-induced demyelination in rats. 2. Ultrastructural evolution. Acta Neuropathol. (Berl.)88, 293–299 (1994).
   PubMedGoogle Scholar
• Norenberg MD, Papendick RE. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann. Neurol.15, 544–547 (1984).
   PubMed Web of Science ®Google Scholar
• Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int.391274–1282 (1991).
   PubMedGoogle Scholar
• Adler S, Verbalis JG, Williams D. Effect of rapid correction of hyponatremia on the blood–brain barrier of rats. Brain Res.679, 135–143 (1995).
   PubMedGoogle Scholar
• Sugimura Y, Murase T, Takefuji S et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp. Neurol.192(1), 178–183 (2005).
   PubMedGoogle Scholar
• Thurston JH, Hauhart RE, Nelson JS. Adaptive decreases in amino acids (taurine in particular), creatine, and electrolytes prevent cerebral edema in chronically hyponatremic mice: rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain. Metab. Brain Dis.2, 223–241 (1987).
   PubMedGoogle Scholar
• Lien YH. Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia. J. Clin. Invest.95, 1579–1586 (1995).
   PubMedGoogle Scholar
• Soupart A, Silver S, Schrooeder B, Sterns R, Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J. Am. Soc. Nephrol.13, 1433–1441 (2002).
   PubMed Web of Science ®Google Scholar
• Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J. Neuropathol. Exp. Neurol.65, 37–44 (2006).
   PubMedGoogle Scholar
• Alfieri RR, Cavazzoni A, Petronini PG et al. Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J. Physiol.540, 499–508 (2002).
   PubMed Web of Science ®Google Scholar
• Fux M, Levine J, Aviv A, Belmaker RH. Inositol treatment of obsessive-compulsive disorder. Am. J. Psychiatry153, 1219–1221 (1996).
   PubMed Web of Science ®Google Scholar
• Kaplan Z, Amir M, Swartz M, Levine J. Inositol treatment of post-traumatic stress disorder. Anxiety2, 51–52 (1996).
   PubMedGoogle Scholar
• Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N. Engl. J. Med.314, 1535–1542 (1986).
   PubMed Web of Science ®Google Scholar
• Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N. Engl. J. Med.317, 1190–1195 (1987).
   PubMed Web of Science ®Google Scholar
• Sterns RH. Neurological deterioration following treatment for hyponatremia. Am. J. Kidney Dis.13, 434–437 (1989).
   PubMedGoogle Scholar
• Brunner JE, Redmond JM, Haggar AM, Kruger DF, Elias SB. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann. Neurol.27, 61–66 (1990).
   PubMed Web of Science ®Google Scholar
• Brunner JE, Redmond JM, Haggar AM, Elias SB. Central pontine myelinolysis after rapid correction of hyponatremia: a magnetic resonance imaging study. Ann. Neurol.23, 389–391 (1988).
   PubMedGoogle Scholar
• Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann. Intern. Med.126, 57–62 (1997).
   PubMed Web of Science ®Google Scholar
• Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore)72, 359–373 (1993).
   PubMed Web of Science ®Google Scholar
• Laubenberger J, Schneider B, Ansorge O et al. Central pontine myelinolysis: clinical presentation and radiologic findings. Eur. Radiol.,6, 177–183 (1996).
   PubMed Web of Science ®Google Scholar
• Tanneau RS, Henry A, Rouhart F et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J. Clin. Psychiatry55, 349–354 (1994).
   PubMed Web of Science ®Google Scholar
• Lin SH, Chau T, Wu CC, Yang SS. Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline. Am. J. Med. Sci.323, 259–262 (2002).
   PubMed Web of Science ®Google Scholar
• Adrogue HJ, Madias NE. Hyponatremia. N. Engl. J. Med.342, 1581–1589 (2000).
   PubMed Web of Science ®Google Scholar
• Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int.45, 193–200 (1994).
   PubMed Web of Science ®Google Scholar
• Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin. Nephrol.51, 383–386 (1999).
   PubMed Web of Science ®Google Scholar
• Oh MS, Uribarri J, Barrido D, Landman E, Choi KC, Carroll HJ. Danger of central pontine myelinolysis in hypotonic dehydration and recommendation for treatment. Am. J. Med. Sci.298, 41–43 (1989).
   PubMedGoogle Scholar
• Schrier R, Gross P, Gheorghiade M et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med.355, 2099–2112 (2006).
   PubMed Web of Science ®Google Scholar
• Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int.69, 2124–2130 (2006).
   PubMed Web of Science ®Google Scholar
• Soupart A, Gross P, Legros J-J et al. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR-121463B), an orally active vasopressin V2 receptor antagonist. Clin. J. Am. Soc. Nephrol.1, 1154–1160 (2006).
   PubMed Web of Science ®Google Scholar